Julie Kish

Julie Kish

UNVERIFIED PROFILE

Are you Julie Kish?   Register this Author

Register author
Julie Kish

Julie Kish

Publications by authors named "Julie Kish"

Are you Julie Kish?   Register this Author

18Publications

558Reads

36Profile Views

Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742).

J Clin Oncol 2018 05 27;36(14):1412-1418. Epub 2018 Mar 27.

Brigette B.Y. Ma, Edwin P. Hui, Kwok-Wai Lo, Ka-Fai To, K.C. Allen Chan, Y.M. Dennis Lo, Ann D. King, and Anthony T.C. Chan, The Chinese University of Hong Kong, Shatin, Hong Kong, Special Administrative Region, People's Republic of China; Wan-Teck Lim, National Cancer Centre; Boon-Cher Goh, National University Cancer Institute of Singapore; Alex Y.C. Chang, Johns Hopkins University School of Medicine; Akhil Chopra, OncoCare Cancer Centre, Singapore; Adam Pettinger, Nathan R. Foster, Charles Erlichman, Jun Yin, and Brian A. Costello, Mayo Clinic, Rochester, MN; Jonathan W. Riess, University of California Davis Comprehensive Cancer Center, Sacramento; Barbara J. Gitlitz, University of Southern California Keck School of Medicine, Los Angeles; Dean W. Lim, City of Hope Comprehensive Cancer Center, Duarte, CA; Mark Agulnik, Northwestern University, Evanston, IL; Julie A. Kish and Christine H. Chung, Moffitt Cancer Center, University of South Florida, Tampa, FL; Douglas R. Adkins, Washington University School of Medicine, St Louis, MO; Kevin J. Cullen, University of Maryland, Baltimore, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.77.0388DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5941615PMC
May 2018

Increased acute mortality with chemoradiotherapy for locally advanced head and neck cancer in patients ≥70years.

J Geriatr Oncol 2017 01 3;8(1):50-55. Epub 2016 Oct 3.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jgo.2016.09.003DOI Listing
January 2017

Adjuvant radiotherapy versus concurrent chemoradiotherapy for the management of high-risk salivary gland carcinomas.

Head Neck 2016 11 21;38(11):1628-1633. Epub 2016 Apr 21.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.24484DOI Listing
November 2016

Determining optimal follow-up in the management of human papillomavirus-positive oropharyngeal cancer.

Cancer 2016 Feb 13;122(4):634-41. Epub 2015 Nov 13.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.29782DOI Listing
February 2016

Comparison of every 3 week cisplatin or weekly cetuximab with concurrent radiotherapy for locally advanced head and neck cancer.

Oral Oncol 2015 Jul 30;51(7):704-8. Epub 2015 Apr 30.

Department of Radiation Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.04.012DOI Listing
July 2015

Postoperative concurrent chemotherapy and radiotherapy for high-risk cutaneous squamous cell carcinoma of the head and neck.

Head Neck 2015 Jun 27;37(6):840-5. Epub 2014 Jun 27.

Department of Head and Neck Oncology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23684DOI Listing
June 2015

A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors.

Clin Cancer Res 2014 Mar 15;20(6):1644-55. Epub 2014 Jan 15.

Authors' Affiliations: Departments of Thoracic Oncology, Head and Neck Oncology, and Cutaneous Oncology; Chemical Biology and Molecular Medicine Program; Clinical Pharmacology Core; Biostatistics Core, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida; and Karmanos Cancer Institute, Detroit, Michigan.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-2235DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4051132PMC
March 2014

Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma.

Head Neck 2013 Dec 6;35(12):1796-800. Epub 2013 Mar 6.

Head and Neck Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/hed.23245DOI Listing
December 2013

Risk factors for percutaneous endoscopic gastrostomy tube placement during chemoradiotherapy for oropharyngeal cancer.

JAMA Otolaryngol Head Neck Surg 2013 Nov;139(11):1242-6

Department of Radiation Oncology, Moffitt Cancer Center, Tampa, Florida.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2013.5193DOI Listing
November 2013